Bigfoot Biomedical CEO hits back against CMS over data-sharing decision


Bigfoot BiomedicalBigfoot Biomedical CEO Jeffrey Brewer has spoken out about a recent data-sharing decision made by CMS, saying that he plans to lobby Medicare to reverse its latest move.

Earlier this year, CMS said it would begin covering the use of particular continuous glucose monitors for people with diabetes. But since that decision, the agency has said that if a beneficiary uses a non-durable medical equipment device, like a smartphone, separately or in combination with a device classified as DME, it will not be reimbursed.

In other words, according to Brewer, Medicare will not reimburse for ‘s (NSDQ:DXCM) G5 smartphone app. The chief executive said that people who use Dexcom’s glucose monitor have reported that they can’t use the company’s share function that allows a family member or another person to remotely monitor the user’s glucose levels.

Get the full story on our sister site Drug Delivery Business News. 

NEW! Technology Track at DeviceTalks Boston

textadimage These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.

View Technology Track Featured Sessions

Register today to save. Use code TECHTRACK to save an additional 10%.

Speak Your Mind